Review




Structured Review

BioFire Defense rp2.1 plus reagent pouches
Rp2.1 Plus Reagent Pouches, supplied by BioFire Defense, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rp2%2E1+plus+reagent+pouches/biofire+rp2+1/pm40562548-33-35-34
Average 90 stars, based on 1 article reviews
rp2.1 plus reagent pouches - by Bioz Stars, 2026-10
90/100 stars

Images

Related Articles

Multiplex Assay:

Article Title: Rapid respiratory microbiological point-of-care-testing and antibiotic prescribing in primary care: Protocol for the RAPID-TEST randomised controlled trial
Article Snippet: At the central laboratory, these samples are tested for the presence of respiratory viral and bacterial pathogens using a Taqman Low Density polymerase chain reaction array card assay [ ] as well as the same BioFire ® RP2.1 plus reagent pouches run on the Biofire ® Filmarray ® Torch 1 system used at the GP practices.

Article Title: Patient perceptions of primary care rapid respiratory microbiological point-of-care testing: a qualitative study.
Article Snippet: The qualitative study was embedded in a multicentre, individually randomised controlled efficacy trial to evaluate multiplex RM- POCTs for suspected RTIs in primary care.15 The multiplex RM- POCTs used in this trial were the BioFire RP2.1 plus reagent pouches with the BioFire FilmArray Torch 1.16 The test results indicate the presence or absence of 23 upper respiratory microbes—19 viruses: influenza A (no subtype detected, H1, H1- 2009, H3), influenza B, adenovirus, Coronaviruses (HKU1, NL63, 229E, OC43, Mers- CoV, SARS- CoV- 2), human metapneumovirus, human rhinovirus/enterovirus (not possible to distinguish due to genetic similarity), parainfluenza (types 1, 2, 3, 4) and respiratory syncytial virus (RSV) and four atypical bacteria: Bordetella pertussis, Bordetella parapertussis, Chlamydia pneumoniae and Mycoplasma pneumonia.

Virus:

Article Title: Rapid respiratory microbiological point-of-care-testing and antibiotic prescribing in primary care: Protocol for the RAPID-TEST randomised controlled trial
Article Snippet: At the central laboratory, these samples are tested for the presence of respiratory viral and bacterial pathogens using a Taqman Low Density polymerase chain reaction array card assay [ ] as well as the same BioFire ® RP2.1 plus reagent pouches run on the Biofire ® Filmarray ® Torch 1 system used at the GP practices.

Article Title: Patient perceptions of primary care rapid respiratory microbiological point-of-care testing: a qualitative study.
Article Snippet: The qualitative study was embedded in a multicentre, individually randomised controlled efficacy trial to evaluate multiplex RM- POCTs for suspected RTIs in primary care.15 The multiplex RM- POCTs used in this trial were the BioFire RP2.1 plus reagent pouches with the BioFire FilmArray Torch 1.16 The test results indicate the presence or absence of 23 upper respiratory microbes—19 viruses: influenza A (no subtype detected, H1, H1- 2009, H3), influenza B, adenovirus, Coronaviruses (HKU1, NL63, 229E, OC43, Mers- CoV, SARS- CoV- 2), human metapneumovirus, human rhinovirus/enterovirus (not possible to distinguish due to genetic similarity), parainfluenza (types 1, 2, 3, 4) and respiratory syncytial virus (RSV) and four atypical bacteria: Bordetella pertussis, Bordetella parapertussis, Chlamydia pneumoniae and Mycoplasma pneumonia.

Bacteria:

Article Title: Rapid respiratory microbiological point-of-care-testing and antibiotic prescribing in primary care: Protocol for the RAPID-TEST randomised controlled trial
Article Snippet: At the central laboratory, these samples are tested for the presence of respiratory viral and bacterial pathogens using a Taqman Low Density polymerase chain reaction array card assay [ ] as well as the same BioFire ® RP2.1 plus reagent pouches run on the Biofire ® Filmarray ® Torch 1 system used at the GP practices.

Article Title: Patient perceptions of primary care rapid respiratory microbiological point-of-care testing: a qualitative study.
Article Snippet: The qualitative study was embedded in a multicentre, individually randomised controlled efficacy trial to evaluate multiplex RM- POCTs for suspected RTIs in primary care.15 The multiplex RM- POCTs used in this trial were the BioFire RP2.1 plus reagent pouches with the BioFire FilmArray Torch 1.16 The test results indicate the presence or absence of 23 upper respiratory microbes—19 viruses: influenza A (no subtype detected, H1, H1- 2009, H3), influenza B, adenovirus, Coronaviruses (HKU1, NL63, 229E, OC43, Mers- CoV, SARS- CoV- 2), human metapneumovirus, human rhinovirus/enterovirus (not possible to distinguish due to genetic similarity), parainfluenza (types 1, 2, 3, 4) and respiratory syncytial virus (RSV) and four atypical bacteria: Bordetella pertussis, Bordetella parapertussis, Chlamydia pneumoniae and Mycoplasma pneumonia.



Similar Products

90
BioFire Defense rp2.1 plus reagent pouches
Rp2.1 Plus Reagent Pouches, supplied by BioFire Defense, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rp2%2E1+plus+reagent+pouches/biofire+rp2+1/pm40562548-33-35-34
Average 90 stars, based on 1 article reviews
rp2.1 plus reagent pouches - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results